NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.37
+0.48 (3.72%)
At close: May 12, 2025, 4:00 PM
13.94
+0.57 (4.26%)
After-hours: May 12, 2025, 5:21 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $437.90 million as of May 12, 2025. Its market cap has increased by 12.44% in one year.
Market Cap
437.90M
Enterprise Value
458.49M
1-Year Change
12.44%
Ranking
Category
Stock Price
$13.37
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $437.90M, an increase of 11.35%. That is a compound annual growth rate of 2.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 422.18M | 26.40% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |